Highly shifted LIPOCEST agents based on the encapsulation of neutral polynuclear paramagnetic shift reagents

Department of Chemisry IFM and Molecular Imaging Center, University of Torino, Via P. Giuria 7, I-10125, Torino, Italy.
Chemical Communications (Impact Factor: 6.83). 03/2008; 5(5):600-2. DOI: 10.1039/b715383j
Source: PubMed


Improved LIPOCEST MRI contrast agents with highly shifted intraliposomal water protons were prepared by entrapping neutral polynuclear Tm(III)-based paramagnetic shift reagents in phospholipidic vesicles.

Download full-text


Available from: Jebasingh Bhagavathsingh, Jul 14, 2015
24 Reads
  • Source
    • "Paramagnetic CEST agents are ideally suited for molecular imaging applications because one can switch the contrast on and off as desired simply by adjusting the pulse sequence parameters. Liposome-based CEST agents have shown great sensitivity and potential for molecular MRI.70 "
    [Show abstract] [Hide abstract]
    ABSTRACT: Targeted therapy is becoming an increasingly important component in the treatment of cancer. How to accurately monitor targeted therapy has been crucial in clinical practice. The traditional approach to monitor treatment through imaging has relied on assessing the change of tumor size by refined World Health Organization criteria, or more recently, by the Response Evaluation Criteria in Solid Tumors. However, these criteria, which are based on the change of tumor size, show some limitations for evaluating targeted therapy. Currently, genetic alterations are identified with prognostic as well as predictive potential concerning the use of molecularly targeted drugs. Conversely, considering the limitations of invasiveness and the issue of expression heterogeneity, molecular imaging is better able to assay in vivo biologic processes noninvasively and quantitatively, and has been a particularly attractive tool for monitoring treatment in clinical cancer practice. This review focuses on the applications of different kinds of molecular imaging including positron emission tomography-, magnetic resonance imaging-, ultrasonography-, and computed tomography-based imaging strategies on monitoring targeted therapy. In addition, the key challenges of molecular imaging are addressed to successfully translate these promising techniques in the future.
    International Journal of Nanomedicine 09/2013; 8:3703-3713. DOI:10.2147/IJN.S51264 · 4.38 Impact Factor
  • Source
  • Gait & Posture 04/1996; 4(2):180-180. DOI:10.1016/0966-6362(96)80600-X · 2.75 Impact Factor
Show more